Home  /  Resource Library  /  Preliminary study results of orelabrutinib in combination with rituximab for treatment-Naive marginal zone lymphoma: A prospective single-arm clinical trial

Preliminary study results of orelabrutinib in combination with rituximab for treatment-Naive marginal zone lymphoma: A prospective single-arm clinical trial

ASH 2025